MedReleaf (TSE:LEAF) had its price objective raised by Cowen from C$20.00 to C$36.00 in a research note issued to investors on Monday morning.

A number of other equities analysts have also weighed in on the stock. Canaccord Genuity lifted their price objective on shares of MedReleaf from C$15.00 to C$20.00 in a research report on Tuesday, November 14th. Eight Capital lifted their price objective on shares of MedReleaf from C$13.00 to C$20.00 and gave the company a buy rating in a research report on Wednesday, November 15th.

MedReleaf (TSE LEAF) opened at C$26.40 on Monday. The company has a market cap of $2,500.00 and a price-to-earnings ratio of 1,320.00. MedReleaf has a 1-year low of C$6.81 and a 1-year high of C$31.25.

COPYRIGHT VIOLATION WARNING: “Cowen Raises MedReleaf (LEAF) Price Target to C$36.00” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.watchlistnews.com/cowen-raises-medreleaf-leaf-price-target-to-c36-00/1802134.html.

MedReleaf Company Profile

Receive News & Ratings for MedReleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedReleaf and related companies with MarketBeat.com's FREE daily email newsletter.